Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × selpercatinib × Clear all

Status

Active not recruiting 11 Recruiting 5 Not yet recruiting 2 Withdrawn 1 Unknown 1 Completed 1 Approved for marketing 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Thyroid Diseases 1

Interventions

Cyclophosphamide 1486 Cisplatin 1421 Paclitaxel 1335 Radiotherapy 1300 Carboplatin 1258 Gemcitabine 1221 Docetaxel 1131 Bevacizumab 1064 Fluorouracil 900 Doxorubicin 794 Dexamethasone 749 Rituximab 742 Capecitabine 734 Oxaliplatin 705 pembrolizumab 678 Etoposide 670 Irinotecan 634 Filgrastim 623 Cytarabine 583 Nivolumab 577 Leucovorin 577 Vincristine 508 Cetuximab 475 Prednisone 474 Bortezomib 472 Trastuzumab 468 Erlotinib Hydrochloride 466 Surveys and Questionnaires 454 Methotrexate 440 Lenalidomide 435

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07543887 2026-04-22

EECRTKI

University of Pisa

Thyroid Diseases, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡